by Tony Pullen •
April 27, 2015 •
Business Focus, Capital markets/Funding, Editor's Picks, Feature Slider, Featured-Slides-Home •
Comments (0) •
A little over a year ago I decided to weigh in on the original question, captioned above. My purpose was to share my observations gleaned from operating as an investment banker in the space since the mid ’80s.
Comments are closed.
© 2017 Biotechnology Focus™
Powered by Wordpress. Designed by Themnific™